Rchr
J-GLOBAL ID：200901050653578992   Update date: Apr. 17, 2024

Hiramatsu Hidefumi

ヒラマツ ヒデフミ | Hiramatsu Hidefumi
Affiliation and department：
Kyoto University Hospital, Pediatrics

About Kyoto University Hospital, Pediatrics


Job title： Lecturer
Research field  (3)： Hematology and oncology ,  Fetal medicine/Pediatrics ,  Fetal medicine/Pediatrics
Research keywords  (7)： microRNA ,  pediatric leukemia ,  CAR-T ,  minimal residual disease ,  CAR-T cell therapy ,  造血幹細胞 ,  小児血液 小児腫瘍
Research theme for competitive and other funds  (10)：
  • 2019 - 2022 translational research for novel therapy for leukemia utilizing microRNA expression analysis
  • 2015 - 2018 identification for leukemic stem cells using microRNA sensor vector for developing new therapy
  • 2012 - 2015 Identification and characterization of novel human hematopoietic stem cell populations using the micro-RNA sensor vector
  • 2011 - 2012 Development of the next-generation medical treatment for muscularDystrophy
  • 2006 - 2007 Establishment of therapeutic strategy for degenerative muscular disease by embryonic stem mils
Show all
Papers (111)：
  • Yoko Kawamura, Kayoko Nakanishi, Yuri Murata, Kazuki Teranishi, Ryusuke Miyazaki, Keisuke Toda, Toru Imai, Yasuhiro Kajiwara, Keiji Nakagawa, Hidemasa Matsuo, et al. Label-free cell detection of acute leukemia using ghost cytometry. Cytometry Part A. 2024. 105. 3. 196-202
  • Hirohito Kubota, Hiroo Ueno, Keiji Tasaka, Tomoya Isobe, Satoshi Saida, Itaru Kato, Katsutsugu Umeda, Mitsuteru Hiwatari, Daiichiro Hasegawa, Toshihiko Imamura, et al. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood Advances. 2023
  • Yoko Kawamura, Kayoko Nakanishi, Yuri Murata, Kazuki Teranishi, Ryusuke Miyazaki, Keisuke Toda, Toru Imai, Yasuhiro Kajiwara, Keiji Nakagawa, Hidemasa Matsuo, et al. Label-Free Cell Detection of Acute Leukemia Using High-Content Morphological Profiling in Flow. Blood. 2023. 142. Supplement 1. 906-906
  • Daisuke Tomizawa, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Daisuke Hasegawa, Hiroshi Moritake, Daiichiro Hasegawa, Kiminori Terui, Asahito Hama, Shin-Ichi Tsujimoto, et al. High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia. Leukemia. 2023
  • 辻本 信一, 加登 翔太, 岩本 彰太郎, 平松 英文, 奥野 友介, 神鳥 達哉, 大木 健太郎, 出口 隆生, 清河 信敬, 加藤 元博, et al. KIT変異・FCM-MRDはRUNX1::RUNX1T1RUNX1陽性小児AMLにおける予後予測因子である. 日本血液学会学術集会. 2023. 85回. 142-142
ｍore...
MISC (289)：
  • 児玉 祐一, 西 眞範, 佐藤 篤, 今村 知世, 出口 隆生, 平川 晃弘, 清河 信敬, 大木 健太郎, 嶋 晴子, 加藤 啓輔, et al. 小児再発・難治フィラデルフィア染色体陽性白血病に対するポナチニブ安全性確認試験. 日本血液学会学術集会. 2022. 84回. 1362-1362
  • 森谷 邦彦, 今村 俊彦, 片山 紗乙莉, 戒能 明, 岡本 賢治, 横山 能文, 植村 優, 北澤 宏展, 関水 匡大, 平松 英文, et al. BFM基盤のプロトコールで治療をした日本人小児急性リンパ性白血病における症候性骨壊死の発症率は欧米人と同時である(Incidence of symptomatic ON in pediatric ALL treated with BFM based protocol is similar to children in western countries). 日本小児科学会雑誌. 2022. 126. 2. 294-294
  • Atsushi Sato, Hirohide Kawasaki, Takao Deguchi, Yoshiko Hashii, Yuka Iijima-Yamashita, Sachiko Yonezawa, Chiyo K. Imamura, Haruko Shima, Hirotoshi Sakaguchi, Yuichi Kodama, et al. Chemotherapy with the Use of TKIs Based on MRD Has the Potential to Avoid Hematopoietic Stem Cell Transplantation in Treatment for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL). Results of the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study ALL-Ph13. BLOOD. 2021. 138
  • 大部 聡, 梅田 雄嗣, 才田 聡, 加藤 格, 平松 英文, 荒川 芳輝, 宇藤 恵, 溝脇 尚志, 足立 壮一, 滝田 順子. 頭蓋内germinomaの診断における髄液中胎盤型アルカリフォスファターゼ(PLAP)の有用性. 日本小児血液・がん学会雑誌. 2021. 58. 4. 295-295
  • Yuichi Kodama, Atsushi Sato, Keisuke Kato, Motohiro Kato, Hirohide Kawasaki, Hirotoshi Sakaguchi, Hidefumi Hiramatsu, Itaru Kato, Takashi Taga, Hiroyuki Shimada. Ponatinib in Pediatric Patients with Philadelphia Chromosome-Positive Leukemia - Japanese Pediatric Leukemia/Lymphoma Study Group. PEDIATRIC BLOOD & CANCER. 2020. 67
ｍore...
Patents (1)：
  • USE OF MIR-126 FOR ENHANCING HEMATOPOIETIC STEM CELL ENGRAFTMENT, FOR ISOLATING HEMATOPOIETIC STEM CELLS, AND FOR TREATING AND MONITORING THE TREATMENT OF ACUTE MYELOID LEUKEMIA
Professional career (1)：
  • 医学博士 (京都大学)
Association Membership(s) (6)：
THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY ,  日本小児科学会 ,  Japanese Cancer Association ,  American Society of Hematology ,  日本造血細胞移植学会 ,  THE JAPANESE SOCIETY OF HEMATOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM